National Cancer Database (NCDB)

item # our brief description our category our code
1 % bladder cancer 5-year survival rate stage 0 bladder cancer bladder0
2 % bladder cancer 5-year survival rate stage 1 bladder cancer bladder1
3 % bladder cancer 5-year survival rate stage 2 bladder cancer bladder2
4 % bladder cancer 5-year survival rate stage 3 bladder cancer bladder3
5 % bladder cancer 5-year survival rate stage 4 bladder cancer bladder4
6 % breast cancer 5-year survival rate stage 0 breast cancer breast0
7 % breast cancer 5-year survival rate stage 1 breast cancer breast1
8 % breast cancer 5-year survival rate stage 2 breast cancer breast2
9 % breast cancer 5-year survival rate stage 3 breast cancer breast3
10 % breast cancer 5-year survival rate stage 4 breast cancer breast4
11 % cervical cancer 5-year survival rate stage 0 cervical cancer cervical0
12 % cervical cancer 5-year survival rate stage 1 cervical cancer cervical1
13 % cervical cancer 5-year survival rate stage 2 cervical cancer cervical2
14 % cervical cancer 5-year survival rate stage 3 cervical cancer cervical3
15 % cervical cancer 5-year survival rate stage 4 cervical cancer cervical4
16 % colon cancer 5-year survival rate stage 0 colon cancer colon0
17 % colon cancer 5-year survival rate stage 1 colon cancer colon1
18 % colon cancer 5-year survival rate stage 2 colon cancer colon2
19 % colon cancer 5-year survival rate stage 3 colon cancer colon3
20 % colon cancer 5-year survival rate stage 4 colon cancer colon4
21 % kidney cancer 5-year survival rate stage 0 kidney cancer kidney0
22 % kidney cancer 5-year survival rate stage 1 kidney cancer kidney1
23 % kidney cancer 5-year survival rate stage 2 kidney cancer kidney2
24 % kidney cancer 5-year survival rate stage 3 kidney cancer kidney3
25 % kidney cancer 5-year survival rate stage 4 kidney cancer kidney4
26 % lung cancer (non-small cell) 5-year survival rate stage 0 lung cancer (non-small cell) lungnsc0
27 % lung cancer (non-small cell) 5-year survival rate stage 1 lung cancer (non-small cell) lungnsc1
28 % lung cancer (non-small cell) 5-year survival rate stage 2 lung cancer (non-small cell) lungnsc2
29 % lung cancer (non-small cell) 5-year survival rate stage 3 lung cancer (non-small cell) lungnsc3
30 % lung cancer (non-small cell) 5-year survival rate stage 4 lung cancer (non-small cell) lungnsc4
31 % lung cancer (small cell) 5-year survival rate stage 0 lung cancer (small cell) lungsc0
32 % lung cancer (small cell) 5-year survival rate stage 1 lung cancer (small cell) lungsc1
33 % lung cancer (small cell) 5-year survival rate stage 2 lung cancer (small cell) lungsc2
34 % lung cancer (small cell) 5-year survival rate stage 3 lung cancer (small cell) lungsc3
35 % lung cancer (small cell) 5-year survival rate stage 4 lung cancer (small cell) lungsc4
36 % skin cancer (melanoma) 5-year survival rate stage 0 skin cancer (melanoma) skin0
37 % skin cancer (melanoma) 5-year survival rate stage 1 skin cancer (melanoma) skin1
38 % skin cancer (melanoma) 5-year survival rate stage 2 skin cancer (melanoma) skin2
39 % skin cancer (melanoma) 5-year survival rate stage 3 skin cancer (melanoma) skin3
40 % skin cancer (melanoma) 5-year survival rate stage 4 skin cancer (melanoma) skin4
41 % prostate cancer 5-year survival rate stage 0 prostate cancer prostate0
42 % prostate cancer 5-year survival rate stage 1 prostate cancer prostate1
43 % prostate cancer 5-year survival rate stage 2 prostate cancer prostate2
44 % prostate cancer 5-year survival rate stage 3 prostate cancer prostate3
45 % prostate cancer 5-year survival rate stage 4 prostate cancer prostate4
46 % rectal cancer 5-year survival rate stage 0 rectal cancer rectal0
47 % rectal cancer 5-year survival rate stage 1 rectal cancer rectal1
48 % rectal cancer 5-year survival rate stage 2 rectal cancer rectal2
49 % rectal cancer 5-year survival rate stage 3 rectal cancer rectal3
50 % rectal cancer 5-year survival rate stage 4 rectal cancer rectal4
51 % uterine cancer 5-year survival rate stage 0 uterine cancer uterine0
52 % uterine cancer 5-year survival rate stage 1 uterine cancer uterine1
53 % uterine cancer 5-year survival rate stage 2 uterine cancer uterine2
54 % uterine cancer 5-year survival rate stage 3 uterine cancer uterine3
55 % uterine cancer 5-year survival rate stage 4 uterine cancer uterine4

For more information about Norton Healthcare's Quality Report please email us at quality@nortonhealthcare.org.
View the Quality Report Disclaimer.